Co-stimulation of CLL cells with the TLR9 agonist CpG and GRN in which we did not observe an additive effect on cell proliferation suggested, that this interaction does not play a significant role in human CLL cells in vitro. This evidence concerns the gene GRN and B-cell chronic lymphocytic leukemia.